Alcon Sues Apotex Over Generic Allergy Spray
Alcon, a subsidiary of Novartis AG, lodged the suit in response to Apotex's filing of an abbreviated new drug application with the U.S. Food and Drug Administration to sell a generic olopatadine hydrochloride product before the plaintiff's patent for the drug expires.
Alcon claims that Apotex's ANDA infringes U.S. Patent...
Already a subscriber? Click here to login